FindTrial
Sign In

Randomized double-blind trial to study the benefit of Colchicine in Patients with Acutely Decompensated Heart Failure

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504165-23-00
Acronym
IMIB-CO-2020-01
Enrollment
302
Registered
2023-03-03
Start date
2021-02-08
Completion date
2024-04-30
Last updated
2023-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute decompensated heart failure

Brief summary

Decreased NT-proBNP levels

Detailed description

Improvement of clinical stability, Mortality rate reduction, Total days of hospitalization

Interventions

DRUGCOLCHICINA SEID 0
DRUG5 mg comprimidos

Sponsors

Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia, Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Decreased NT-proBNP levels—

Secondary

MeasureTime frame
Improvement of clinical stability, Mortality rate reduction, Total days of hospitalization—

Countries

Italy, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026